FibroBiologics Inc. (FBLG) vs IMMURON (IMRN)
FibroBiologics Inc. and IMMURON are both Biotechnology companies. FibroBiologics Inc. and IMMURON are of similar size ($9.6M and $9.1M). FibroBiologics Inc. has the higher net margin (0.00% vs −262.7%) and the lower return on invested capital (−932.7% vs 0.00%). Across the 9 metrics below, IMMURON leads on 7 and FibroBiologics Inc. on 2.
Valuation
Profitability
| Metric | FBLG | IMRN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 71.28% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (262.71%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (660.08%) | 0.00% | (57.72%) |
| Return on assets | (166.14%) | 0.00% | (49.22%) |
| Return on invested capital | (932.71%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack